129 research outputs found
Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology.
BACKGROUND:
We aimed to evaluate the impact of thrombus aspiration (TA) during primary percutaneous coronary intervention (P-PCI) in 'real-world' settings.
METHODS:
We performed a retrospective study, using data from the National Registry of Interventional Cardiology (RNCI 2006-2012, Portugal) with ST-elevation myocardial infarction (STEMI) patients treated with P-PCI. The primary outcome, in-hospital mortality, was analysed through adjusted odds ratio (aOR) and 95% confidence intervals (95%CI).
RESULTS:
We assessed data for 9458 STEMI patients that undergone P-PCI (35% treated with TA). The risk of in-hospital mortality with TA (aOR 0.93, 95%CI:0.54-1.60) was not significantly decreased. After matching patients through the propensity score, TA reduced significantly the risk of in-hospital mortality (OR 0.58, 95%CI:0.35-0.98; 3500 patients).
CONCLUSIONS:
The whole cohort data does not support the routine use of TA in P-PCI, but the results of the propensity-score matched cohort suggests that the use of selective TA may improve the short-term risks of STEMI.info:eu-repo/semantics/publishedVersio
Approaches in biotechnological applications of natural polymers
Natural polymers, such as gums and mucilage, are biocompatible, cheap, easily available and non-toxic materials of native origin. These polymers are increasingly preferred over synthetic materials for industrial applications due to their intrinsic properties, as well as they are considered alternative sources of raw materials since they present characteristics of sustainability, biodegradability and biosafety. As definition, gums and mucilages are polysaccharides or complex carbohydrates consisting of one or more monosaccharides or their derivatives linked in bewildering variety of linkages and structures. Natural gums are considered polysaccharides naturally occurring in varieties of plant seeds and exudates, tree or shrub exudates, seaweed extracts, fungi, bacteria, and animal sources. Water-soluble gums, also known as hydrocolloids, are considered exudates and are pathological products; therefore, they do not form a part of cell wall. On the other hand, mucilages are part of cell and physiological products. It is important to highlight that gums represent the largest amounts of polymer materials derived from plants. Gums have enormously large and broad applications in both food and non-food industries, being commonly used as thickening, binding, emulsifying, suspending, stabilizing agents and matrices for drug release in pharmaceutical and cosmetic industries. In the food industry, their gelling properties and the ability to mold edible films and coatings are extensively studied. The use of gums depends on the intrinsic properties that they provide, often at costs below those of synthetic polymers. For upgrading the value of gums, they are being processed into various forms, including the most recent nanomaterials, for various biotechnological applications. Thus, the main natural polymers including galactomannans, cellulose, chitin, agar, carrageenan, alginate, cashew gum, pectin and starch, in addition to the current researches about them are reviewed in this article.. }To the Conselho Nacional de Desenvolvimento CientfĂico e TecnolĂłgico (CNPq) for fellowships (LCBBC and MGCC) and the Coordenação de Aperfeiçoamento de Pessoal de NvĂel Superior (CAPES) (PBSA). This study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit, the Project RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462) and COMPETE 2020 (POCI-01-0145-FEDER-006684) (JAT)
Trends in percutaneous coronary intervention from 2004 to 2013 according to the Portuguese National Registry of Interventional Cardiology
Introducção e objetivos: Foi nosso objetivo estudar as tendĂȘncias da intervencção coronĂĄria percutĂąnea
entre 2004-2013 e comparar Portugal com outros paĂses europeus.
MĂ©todos: AnĂĄlise dos procedimentos coronĂĄrios efetuados entre 2004-2013 com base num
registo prospetivo, multicĂȘntrico, voluntĂĄrio, doente a doente --- Registo Nacional de Cardiologia
de Intervencžão (RNCI) da Associacžão Portuguesa de Intervencžão Cardiovascular da Sociedade
Portuguesa de Cardiologia (APIC-SPC) --- e dos dados oficiais publicados pela Direcžão Geral de
SaĂșde (DGS).
Resultados: Em 2013 realizaram-se 36 810 cateterismos diagnĂłsticos (3529 coronariografias por
milhĂŁo de habitantes), representando um aumento significativo de 34% relativamente ao ano
de 2007 (p < 0,001). As intervencžÔes coronårias percutùneas (ICP) cresceram 64% desde 2004,
atingindo um total de 13 897 procedimentos e uma taxa de 1333 por milhĂŁo de habitantes no ano
de 2013 (p < 0,001). A angioplastia primĂĄria (ICP-P) cresceu 265% (1328 versus 3524) atingindo
uma taxa de 338/milhĂŁo, o que representou 25% do total de angioplastias efectuadas em 2013.
Os stents foram o dispositivo intracoronĂĄrio mais utilizado, com uma taxa de stents eluidores
de fĂĄrmaco de 73% em 2013. O acesso radial passou de 4,1% em 2004 para 57,9% em 2013
(p < 0,001).
ConclusĂ”es: A cardiologia de intervencžão mantĂ©m uma tendĂȘncia de crescimento desde 2004 a
2013. Neste ano, a totalidade dos centros de cardiologia de intervencžão portugueses estavam
a exportar os dados para o RNCI, destacando-se o aumento relativo da angioplastia primĂĄria e
o incremento do acesso radial.Introduction and Objectives: The aim of the present paper is to report trends in Portuguese
interventional cardiology from 2004 to 2013 and to compare them with other European countries.
Methods: Based on the Portuguese National Registry of Interventional Cardiology and on official
data from the Directorate-General of Health, we give an overview of developments in coronary
interventions from 2004 to 2013.
Results: In 2013, 36 810 diagnostic catheterization procedures were performed, representing an
increase of 34% compared to 2007 and a rate of 3529 coronary angiograms per million population.
Coronary interventions increased by 65% in the decade from 2004 to 2013, with a total of 13 897
procedures and a rate of 1333 coronary interventions per million population in 2013. Primary
percutaneous coronary intervention (PCI) increased by 265% from 2004 to 2013 (1328 vs. 3524),
an adjusted rate of 338 primary PCIs per million, representing 25% of total angioplasties. Stents
were the most frequently used devices, drug-eluting stents being used in 73% in 2013. Radial
access increased from 4.1% in 2004 to 57.9% in 2013.
Conclusion: Interventional cardiology in Portugal has been expanding since 2004. We would
emphasize the fact that in 2013 all Portuguese interventional cardiology centers were participating
in the National Registry of Interventional Cardiology, as well as the growth in primary
PCI and increased use of radial access
Mineral trioxyde aggregate versus calcium hydroxide in apexification of non vital immature teeth: Study protocol for a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p>Pulp necrosis is one of the main complications of dental trauma. When it happens on an immature tooth, pulp necrosis implies a lack of root maturation and apical closure. A therapy called apexification is required to induce the formation of a calcified apical barrier allowing a permanent and hermetic root filling. The aim of this prospective randomized clinical trial is to compare Mineral Trioxide Aggregate(MTA)with Calcium Hydroxide(CH)as materials used to induce root-end closure in necrotic permanent immature incisors.</p> <p>Methods/Design</p> <p>This study, promoted by AP-HP, was approved by the ethics committee(CPP Paris Ile de France IV). 34 children aged from 6 to 18 years and presenting a non-vital permanent incisor are selected. Prior to treatment, an appropriate written consent has to be obtained from both parents and from children. Patients are then randomly assigned to either the MTA(experimental)or CH(control)groups. Recalls are performed after 3, 6 and 12 months to determine the presence or absence of a calcified apical barrier through the use of clinical and radiographic exams. Additional criteria such as clinical symptoms, apical radiolucencies, periapical index(PAI)are also noted.</p> <p>Trial registration</p> <p>ClinicalTrials.gov no. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00472173">NCT00472173</a> (First inclusion: May 10, 2007; Last inclusion: April 23, 2009; study completed: April 15, 2010)</p
<i>Gaia</i> Data Release 1. Summary of the astrometric, photometric, and survey properties
Context. At about 1000 days after the launch of Gaia we present the first Gaia data release, Gaia DR1, consisting of astrometry and photometry for over 1 billion sources brighter than magnitude 20.7.
Aims. A summary of Gaia DR1 is presented along with illustrations of the scientific quality of the data, followed by a discussion of the limitations due to the preliminary nature of this release.
Methods. The raw data collected by Gaia during the first 14 months of the mission have been processed by the Gaia Data Processing and Analysis Consortium (DPAC) and turned into an astrometric and photometric catalogue.
Results. Gaia DR1 consists of three components: a primary astrometric data set which contains the positions, parallaxes, and mean proper motions for about 2 million of the brightest stars in common with the HIPPARCOS and Tycho-2 catalogues â a realisation of the Tycho-Gaia Astrometric Solution (TGAS) â and a secondary astrometric data set containing the positions for an additional 1.1 billion sources. The second component is the photometric data set, consisting of mean G-band magnitudes for all sources. The G-band light curves and the characteristics of âŒ3000 Cepheid and RR-Lyrae stars, observed at high cadence around the south ecliptic pole, form the third component. For the primary astrometric data set the typical uncertainty is about 0.3 mas for the positions and parallaxes, and about 1 mas yrâ1 for the proper motions. A systematic component of âŒ0.3 mas should be added to the parallax uncertainties. For the subset of âŒ94 000 HIPPARCOS stars in the primary data set, the proper motions are much more precise at about 0.06 mas yrâ1. For the secondary astrometric data set, the typical uncertainty of the positions is âŒ10 mas. The median uncertainties on the mean G-band magnitudes range from the mmag level to âŒ0.03 mag over the magnitude range 5 to 20.7.
Conclusions. Gaia DR1 is an important milestone ahead of the next Gaia data release, which will feature five-parameter astrometry for all sources. Extensive validation shows that Gaia DR1 represents a major advance in the mapping of the heavens and the availability of basic stellar data that underpin observational astrophysics. Nevertheless, the very preliminary nature of this first Gaia data release does lead to a number of important limitations to the data quality which should be carefully considered before drawing conclusions from the data
The tale of TILs in breast cancer : a report from The International Immuno-Oncology Biomarker Working Group
The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potentially benefit from ICI targeting the programmed death 1 (PD-1)/PD-L1 signaling axis. The use of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarkers has been under intense examination. Emerging data suggest that TILs are associated with response to both cytotoxic treatments and immunotherapy, particularly for patients with triple-negative BC. In this review from The International Immuno-Oncology Biomarker Working Group, we discuss (a) the biological understanding of TILs, (b) their analytical and clinical validity and efforts toward the clinical utility in BC, and (c) the current status of PD-L1 and TIL testing across different continents, including experiences from low-to-middle-income countries, incorporating also the view of a patient advocate. This information will help set the stage for future approaches to optimize the understanding and clinical utilization of TIL analysis in patients with BC
Impact of protozoan cell death on parasite-host interactions and pathogenesis
PCD in protozoan parasites has emerged as a fascinating field of parasite biology. This not only relates to the underlying mechanisms and their evolutionary implications but also to the impact on the parasite-host interactions within mammalian hosts and arthropod vectors. During recent years, common functions of apoptosis and autophagy in protozoa and during parasitic infections have emerged. Here, we review how distinct cell death pathways in Trypanosoma, Leishmania, Plasmodium or Toxoplasma may contribute to regulation of parasite cell densities in vectors and mammalian hosts, to differentiation of parasites, to stress responses, and to modulation of the host immunity. The examples provided indicate crucial roles of PCD in parasite biology. The existence of PCD pathways in these organisms and the identification as being critical for parasite biology and parasite-host interactions could serve as a basis for developing new anti-parasitic drugs that take advantage of these pathways
Recommended from our members
Search for neutral MSSM Higgs bosons decaying to a pair of tau leptons in pp collisions
Peer reviewe
Constraints on parton distribution functions and extraction of the strong coupling constant from the inclusive jet cross section in pp collisions at âs=7 TeV
Peer reviewe
- âŠ